Johnson & Johnson (JNJ +0.6%) unit Janssen-Cilag International NV files a Type II variation application with the European Medicines Agency seeking approval to use DARZALEX (daratumumab), in combination with Takeda's VELCADE (bortezomib), melphalan and prednisone, to treat adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplantation.
The data supporting the filing was generated in the Phase 3 ALCYONE study.
READ FULL ARTICLE HERE
Check, a first-of-its-kind payroll infrastructure startup whose mission is to make paying people simple, announced its public launch today with $35 million in Series B funding from Stripe and Thrive Capital.
MG+M The Law Firm (MG+M) is pleased to announce that it has elevated New York attorney Karina E. Murski
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that Matthew S. Rheingold has been elevated from
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that partners Thomas J. Snyder and Matheu D. Nunn
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
